| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 03.07. | ASIAMEDIC LIMITED: EMPLOYEE STOCK OPTION/SHARE SCHEME::GRANT OF SHARE OPTIONS PURSUANT TO THE ASIAMEDIC EMPLOYEE SHARE OPTION SCHEME 2025 | 2 | SGX Company Announcements | ||
| ASIAMEDIC Aktie jetzt für 0€ handeln | |||||
| 28.05. | ASIAMEDIC LIMITED: ANNUAL GENERAL MEETING::VOLUNTARY | - | SGX Company Announcements | ||
| 14.05. | ASIAMEDIC LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST /CHANGE IN INTEREST - CEO | 2 | SGX Company Announcements | ||
| 29.04. | ASIAMEDIC LIMITED: ANNUAL GENERAL MEETING::VOLUNTARY | 2 | SGX Company Announcements | ||
| 24.04. | ASIAMEDIC LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST /CHANGE IN INTEREST - CEO | 1 | SGX Company Announcements | ||
| 24.04. | ASIAMEDIC LIMITED: GENERAL ANNOUNCEMENT::RESPONSES TO SUBSTANTIAL AND RELEVANT QUESTIONS RECEIVED FROM SHAREHOLDERS - AGM 29 APRIL 2026 | 1 | SGX Company Announcements | ||
| 20.04. | ASIAMEDIC LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST /CHANGE IN INTEREST - CEO | - | SGX Company Announcements | ||
| 20.04. | ASIAMEDIC LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)::DISCLOSURE OF INTEREST /CHANGE IN INTEREST - SUBSTANTIAL SHAREHOLDER (ANG HAO YAO) | - | SGX Company Announcements | ||
| 20.04. | ASIAMEDIC LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)::DISCLOSURE OF INTEREST /CHANGE IN INTEREST - SUBSTANTIAL SHAREHOLDER (INTEGRAL LEAD LIMITED) | - | SGX Company Announcements | ||
| 20.04. | ASIAMEDIC LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)::DISCLOSURE OF INTEREST /CHANGE IN INTEREST - SUBSTANTIAL SHAREHOLDER (DRAGON GLORIOUS LIMITED) | - | SGX Company Announcements | ||
| 20.04. | ASIAMEDIC LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)::DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S) | - | SGX Company Announcements | ||
| 20.04. | ASIAMEDIC LIMITED: EMPLOYEE STOCK OPTION/SHARE SCHEME::ISSUE AND ALLOTMENT OF SHARES PURSUANT TO THE ASIAMEDIC ESOS 2016 | 1 | SGX Company Announcements | ||
| 13.04. | ASIAMEDIC LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER | 3 | SGX Company Announcements | ||
| 13.04. | ASIAMEDIC LIMITED: ANNUAL REPORTS AND RELATED DOCUMENTS | 1 | SGX Company Announcements | ||
| 13.04. | ASIAMEDIC LIMITED: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::DISCREPANCIES BETWEEN UNAUDITED AND AUDITED ACCOUNTS | 1 | SGX Company Announcements | ||
| 13.04. | ASIAMEDIC LIMITED: ANNUAL GENERAL MEETING::VOLUNTARY | - | SGX Company Announcements | ||
| 08.04. | ASIAMEDIC LIMITED: CHANGE - ANNOUNCEMENT OF CESSATION::RETIREMENT OF DIRECTOR | 1 | SGX Company Announcements | ||
| 06.04. | ASIAMEDIC LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)::DISCLOSURE OF INTEREST /CHANGE IN INTEREST - SUBSTANTIAL SHAREHOLDER (INTEGRAL LEAD LIMITED) | - | SGX Company Announcements | ||
| 06.04. | ASIAMEDIC LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)::DISCLOSURE OF INTEREST /CHANGE IN INTEREST - SUBSTANTIAL SHAREHOLDER (DRAGON GLORIOUS LIMITED) | - | SGX Company Announcements | ||
| 06.04. | ASIAMEDIC LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)::DISCLOSURE OF INTEREST /CHANGE IN INTEREST - SUBSTANTIAL SHAREHOLDER (CAPITAL BLAZE LIMITED) | - | SGX Company Announcements |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 35,560 | 0,00 % | UBS stuft Siemens Healthineers auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat das Kursziel für Siemens Healthineers von 51 auf 38 Euro gesenkt, aber die Einstufung auf "Neutral" belassen. Mehrere Risikofaktoren belasteten... ► Artikel lesen | |
| FRESENIUS | 41,690 | 0,00 % | DAX nach Rekord tiefer: Börsen-Beben in Südkorea - Bayer, Rheinmetall, Fresenius und Kion ... | Beim deutschen Leitindex zeichnet sich am Dienstag ein schwächerer Start in den Handelstag ab. Schlechte Vorgaben aus Asien belasten den DAX. Während der Nikkei zur Stunde rund zwei Prozent verliert... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 42,940 | 0,00 % | JPMORGAN stuft FMC FRESENIUS MEDICAL CARE AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat FMC auf "Underweight" mit einem Kursziel von 37,40 Euro belassen. Aus neuesten Daten zu Nierenerkrankungen im Endstadium gehe hervor, dass immer... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 69,63 | -0,01 % | Raymond James initiates BrightSpring Health stock with outperform rating | ||
| HEARTFLOW | 26,160 | 0,00 % | Heartflow, Inc.: New Data at SCCT 2026 Reinforce Heartflow Plaque Analysis as the Standard for AI-Powered Coronary Artery Disease Management | ||
| BILLIONTOONE | 123,25 | 0,00 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 31,560 | 0,00 % | BERNSTEIN RESEARCH stuft CARL ZEISS MEDITEC AG auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat Carl Zeiss Meditec mit einem Kursziel von 26,10 Euro auf "Market-Perform" belassen. Dies schrieb Analystin Susannah Ludwig am... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 20,380 | 0,00 % | Kaplan Fox & Kilsheimer LLP: Kaplan Fox Alerts Investors of Alignment Healthcare, Inc. (ALHC) to an Investigation of Potential Securities Law Violations | New York, New York--(Newsfile Corp. - July 10, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or... ► Artikel lesen | |
| PROGYNY | 31,990 | +0,03 % | KeyBanc raises Progyny stock price target on utilization strength | ||
| ONCOLOGY INSTITUTE | 6,250 | 0,00 % | BTIG hebt Kursziel für Oncology Institute Aktie nach Umschuldung auf 9 US-Dollar an | ||
| BETA BIONICS | 16,960 | +0,06 % | Beta Bionics, Inc.: Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | IRVINE, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 27,890 | 0,00 % | Privia Health Group, Inc. - 8-K, Current Report | ||
| GENEDX | 63,81 | -0,06 % | Piper Sandler raises GeneDx stock price target on coverage policy | ||
| LIFESTANCE HEALTH GROUP | 10,875 | -0,05 % | LifeStance Health Group, Inc. - 8-K, Current Report | ||
| GERRESHEIMER | 28,680 | 0,00 % | SUSS MicroTec: Attacke von BlackRock - Gerresheimer: Drei Fonds, zwei Richtungen | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert, unterliegt Transparenzpflichten gemäß EU-Leerverkaufsverordnung. Ab einer Netto-Leerverkaufsposition von 0,5 Prozent des ausgegebenen Aktienkapitals... ► Artikel lesen |